Cargando…
Real-world evidence in achondroplasia: considerations for a standardized data set
BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, w...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294372/ https://www.ncbi.nlm.nih.gov/pubmed/37365619 http://dx.doi.org/10.1186/s13023-023-02755-w |
_version_ | 1785063181863878656 |
---|---|
author | Alanay, Yasemin Mohnike, Klaus Nilsson, Ola Alves, Inês AlSayed, Moeenaldeen Appelman-Dijkstra, Natasha M. Baujat, Genevieve Ben-Omran, Tawfeg Breyer, Sandra Cormier-Daire, Valerie Gregersen, Pernille Axél Guillén-Navarro, Encarna Högler, Wolfgang Maghnie, Mohamad Mukherjee, Swati Cohen, Shelda Pimenta, Jeanne Selicorni, Angelo Semler, J. Oliver Sigaudy, Sabine Popkov, Dmitry Sabir, Ian Noval, Susana Sessa, Marco Irving, Melita |
author_facet | Alanay, Yasemin Mohnike, Klaus Nilsson, Ola Alves, Inês AlSayed, Moeenaldeen Appelman-Dijkstra, Natasha M. Baujat, Genevieve Ben-Omran, Tawfeg Breyer, Sandra Cormier-Daire, Valerie Gregersen, Pernille Axél Guillén-Navarro, Encarna Högler, Wolfgang Maghnie, Mohamad Mukherjee, Swati Cohen, Shelda Pimenta, Jeanne Selicorni, Angelo Semler, J. Oliver Sigaudy, Sabine Popkov, Dmitry Sabir, Ian Noval, Susana Sessa, Marco Irving, Melita |
author_sort | Alanay, Yasemin |
collection | PubMed |
description | BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, would improve understanding of the natural history of achondroplasia, quality of life, and related outcomes. METHODS: The Europe, Middle East, and Africa (EMEA) Achondroplasia Steering Committee comprises a multidisciplinary team of 17 clinical experts and 3 advocacy organization representatives. The committee undertook an exercise to identify essential data elements for a standardized prospective registry to study the natural history of achondroplasia and related outcomes. RESULTS: A range of RWE on achondroplasia is being collected at EMEA centres. Whereas commonalities exist, the data elements, methods used to collect and store them, and frequency of collection vary. The topics considered most important for collection were auxological measures, sleep studies, quality of life, and neurological manifestations. Data considered essential for a prospective registry were grouped into six categories: demographics; diagnosis and patient measurements; medical issues; investigations and surgical events; medications; and outcomes possibly associated with achondroplasia treatments. CONCLUSIONS: Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02755-w. |
format | Online Article Text |
id | pubmed-10294372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102943722023-06-28 Real-world evidence in achondroplasia: considerations for a standardized data set Alanay, Yasemin Mohnike, Klaus Nilsson, Ola Alves, Inês AlSayed, Moeenaldeen Appelman-Dijkstra, Natasha M. Baujat, Genevieve Ben-Omran, Tawfeg Breyer, Sandra Cormier-Daire, Valerie Gregersen, Pernille Axél Guillén-Navarro, Encarna Högler, Wolfgang Maghnie, Mohamad Mukherjee, Swati Cohen, Shelda Pimenta, Jeanne Selicorni, Angelo Semler, J. Oliver Sigaudy, Sabine Popkov, Dmitry Sabir, Ian Noval, Susana Sessa, Marco Irving, Melita Orphanet J Rare Dis Position Statement BACKGROUND: Collection of real-world evidence (RWE) is important in achondroplasia. Development of a prospective, shared, international resource that follows the principles of findability, accessibility, interoperability, and reuse of digital assets, and that captures long-term, high-quality data, would improve understanding of the natural history of achondroplasia, quality of life, and related outcomes. METHODS: The Europe, Middle East, and Africa (EMEA) Achondroplasia Steering Committee comprises a multidisciplinary team of 17 clinical experts and 3 advocacy organization representatives. The committee undertook an exercise to identify essential data elements for a standardized prospective registry to study the natural history of achondroplasia and related outcomes. RESULTS: A range of RWE on achondroplasia is being collected at EMEA centres. Whereas commonalities exist, the data elements, methods used to collect and store them, and frequency of collection vary. The topics considered most important for collection were auxological measures, sleep studies, quality of life, and neurological manifestations. Data considered essential for a prospective registry were grouped into six categories: demographics; diagnosis and patient measurements; medical issues; investigations and surgical events; medications; and outcomes possibly associated with achondroplasia treatments. CONCLUSIONS: Long-term, high-quality data are needed for this rare, multifaceted condition. Establishing registries that collect predefined data elements across age spans will provide contemporaneous prospective and longitudinal information and will be useful to improve clinical decision-making and management. It should be feasible to collect a minimum dataset with the flexibility to include country-specific criteria and pool data across countries to examine clinical outcomes associated with achondroplasia and different therapeutic approaches. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02755-w. BioMed Central 2023-06-26 /pmc/articles/PMC10294372/ /pubmed/37365619 http://dx.doi.org/10.1186/s13023-023-02755-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Position Statement Alanay, Yasemin Mohnike, Klaus Nilsson, Ola Alves, Inês AlSayed, Moeenaldeen Appelman-Dijkstra, Natasha M. Baujat, Genevieve Ben-Omran, Tawfeg Breyer, Sandra Cormier-Daire, Valerie Gregersen, Pernille Axél Guillén-Navarro, Encarna Högler, Wolfgang Maghnie, Mohamad Mukherjee, Swati Cohen, Shelda Pimenta, Jeanne Selicorni, Angelo Semler, J. Oliver Sigaudy, Sabine Popkov, Dmitry Sabir, Ian Noval, Susana Sessa, Marco Irving, Melita Real-world evidence in achondroplasia: considerations for a standardized data set |
title | Real-world evidence in achondroplasia: considerations for a standardized data set |
title_full | Real-world evidence in achondroplasia: considerations for a standardized data set |
title_fullStr | Real-world evidence in achondroplasia: considerations for a standardized data set |
title_full_unstemmed | Real-world evidence in achondroplasia: considerations for a standardized data set |
title_short | Real-world evidence in achondroplasia: considerations for a standardized data set |
title_sort | real-world evidence in achondroplasia: considerations for a standardized data set |
topic | Position Statement |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294372/ https://www.ncbi.nlm.nih.gov/pubmed/37365619 http://dx.doi.org/10.1186/s13023-023-02755-w |
work_keys_str_mv | AT alanayyasemin realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT mohnikeklaus realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT nilssonola realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT alvesines realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT alsayedmoeenaldeen realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT appelmandijkstranatasham realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT baujatgenevieve realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT benomrantawfeg realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT breyersandra realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT cormierdairevalerie realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT gregersenpernilleaxel realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT guillennavarroencarna realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT hoglerwolfgang realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT maghniemohamad realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT mukherjeeswati realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT cohenshelda realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT pimentajeanne realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT selicorniangelo realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT semlerjoliver realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT sigaudysabine realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT popkovdmitry realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT sabirian realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT novalsusana realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT sessamarco realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset AT irvingmelita realworldevidenceinachondroplasiaconsiderationsforastandardizeddataset |